Study casts doubt on long-term bisphosphonate efficacy
More is not necessarily better in preventing hip fracture, researchers say
Long-term oral bisphosphonate therapy doesn’t seem to give women any extra protection against osteoporotic hip fracture, a new study suggests.
But there’s a hint that staying on the therapy for seven years could be the sweet spot that might spare some women from the morbidity associated with longer term use.
